Denny Neagle

Ask VT AI
View News Summary
  • Centene surprises with a Q3 profit, raises EPS guidance, and records a $6.7B impairment, sending shares higher despite broader market weakness.
  • FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
  • U.S. reduces troop presence in Romania, raising concerns about security gap amid Russia's war in Ukraine.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Centene surprises with a Q3 profit, raises EPS guidance, and records a $6.7B impairment, sending shares higher despite broader market weakness.
  • FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
  • U.S. reduces troop presence in Romania, raising concerns about security gap amid Russia's war in Ukraine.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Denny Neagle